KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $762 | +173.1% | 568,298 | +591.7% | 0.06% | +85.7% |
| Q4 2022 | $279 | -100.0% | 82,162 | -57.2% | 0.04% | -77.4% |
| Q4 2021 | $1,234,000 | +19.8% | 191,976 | +8.5% | 0.16% | +47.6% |
| Q3 2021 | $1,030,000 | +242.2% | 176,996 | +507.4% | 0.10% | +208.8% |
| Q2 2021 | $301,000 | -6.5% | 29,138 | -4.8% | 0.03% | -35.8% |
| Q1 2021 | $322,000 | -5.0% | 30,592 | +39.7% | 0.05% | -3.6% |
| Q4 2020 | $339,000 | – | 21,903 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |